Drugs / sacubitril/valsartan
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03119623 Comparator | Jun 2017 → Aug 2019 | symptomatic heart failure | Brigham and Women's Hospital | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sacubitril/valsartan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03119623 ↗ |
| Modality | Other / unclassified | “an ARNI” NCT03119623 ↗ |
| Route | Oral | “Subjects will be instructed to take one tablet from each container (active one, one placebo) twice daily.” NCT03119623 ↗ |